Alphatec Holdings Inc. (ATEC)

4.08
0.05 1.20
NASDAQ : Health Technology
Prev Close 4.03
Open 4.05
Day Low/High 3.95 / 4.19
52 Wk Low/High 1.58 / 4.27
Volume 359.09K
Avg Volume 69.90K
Exchange NASDAQ
Shares Outstanding 25.47M
Market Cap 102.39M
EPS -0.20
P/E Ratio 13.86
Div & Yield N.A. (N.A)

Latest News

Alphatec Holdings Announces $18.9 Million Private Placement

Proceeds to support corporate growth strategy

Alphatec Spine Appoints Jeffrey G. Black As Chief Financial Officer

Financial executive with extensive public-company experience to help strengthen the Company's foundation and position for growth

Alphatec's Arsenal™ Deformity Adolescent Scoliosis (AIS) System Launched In Limited Markets In The U.S.

Arsenal™ AIS System Used to Successfully Treat First Adolescent Patients

Alphatec Spine Announces Appointment Of David H. Mowry To Its Board Of Directors

Brings over 28 years of orthopedic and medical device experience to Alphatec

Alphatec Holdings Completes Sale Of International Business To Globus Medical

Alphatec Holdings Completes Sale Of International Business To Globus Medical

Substantially reduced debt and improved balance sheet strengthens Alphatec's financial position and enables future growth strategies

Alphatec Holdings Announces One-for-Twelve Reverse Stock Split

Alphatec Holdings Announces One-for-Twelve Reverse Stock Split

Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on August 25, 2016

Alphatec Holdings Announces Sale Of International Business To Globus Medical

Alphatec Holdings Announces Sale Of International Business To Globus Medical

Cash proceeds of $80 million to substantially reduce Company's outstanding debt, allow for continued investment in commercialization and expansion of U.S. business

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.

TheStreet Quant Rating: E+ (Sell)